Peptide Retatrutide 5mg/vial 10mg/vial
Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects, safety, and efficacy for the treatment of obesity are not known. Methods We conducted a phase 2, double-blind, randomized, placebo-controlled trial involving adults who had a body-mass index (BMI, the weight in kilograms divided by the …
Tirzepatide 5mg/vial Peptide 10mg/vial
Tirzepatide is indicated to improve blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise. Tirzepatide is also indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management. Tirzepatide has demonstrated significant benefits in obese patients with a common type of heart failure, preserved ejection fraction (HFpEF) in …
Are you looking into tirzepatide for a specific condition and how it works?
Tirzepatide is a medication primarily used for the treatment of type 2 diabetes and obesity. It’s a dual GIP (Gastric Inhibitory Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor agonist. By targeting both of these hormones, tirzepatide helps regulate blood sugar levels, promote insulin secretion, and reduce appetite, leading to weight loss. It’s sold under the brand name . Tirzepatide has gained …
